Top Markets
#1 Islamic Coin Islamic Coin +152.31%
#2 Bitway Bitway +49.30%
#3 Starpower Starpower +37.29%
#4 aelf aelf +29.81%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +28.60%
#6 SkyAI SkyAI +19.80%
#7 Pons Pons +17.13%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
#9 Decred Decred +14.08%
#10 Bedrock Bedrock +13.96%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Ji Yao Holding Group Co., Ltd. Ji Yao Holding Group Co., Ltd.

Ji Yao Holding Group Co., Ltd.

300108
Rank in Stocks #29833
Ji Yao Holding Group Co., Ltd. functions as a pharmaceutical enterprise,... Ji Yao Holding Group Co., Ltd. functions as a pharmaceutical enterprise, primarily involved in the research, development, production, and wholesale distribution of various medical products. Its extensive product line features both traditional Chinese and modern Western medicines, designed to treat a wide array of health issues. These encompass pediatric conditions, respiratory illnesses, women's health, cardiovascular disorders, viral infections, urinary tract problems, inflammatory diseases, gastrointestinal complaints, general wellness tonics, and rheumatic ailments. The company was founded in 2000 and is headquartered in Meihekou, China.
Share Price
$0.02912824
Last synced: 2025-05-19
Market Cap
$19.41M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade Ji Yao Holding Group Co., Ltd. (300108)

Category

Healthcare
P/E ratio for Ji Yao Holding Group Co., Ltd. (300108)
P/E ratio as of 2026 TTM: 0
According to Ji Yao Holding Group Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Ji Yao Holding Group Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.13 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.